Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Algonquin Power & Utilities
AQN
$4.45B
| $3.65M | ﹤0.01% |
622,905
+73,680
| +13% | +$457K |
|
1702
CALL
Incyte
INCY
$24.3B
| $3.64M | ﹤0.01% |
60,000
+30,000
| +100% | +$1.7M |
|
1703
TechnipFMC
FTI
$27.5B
| $3.63M | ﹤0.01% |
138,717
-35,699
| -20% | -$920K |
|
1704
Choice Hotels
CHH
$5.02B
| $3.63M | ﹤0.01% |
30,464
-17,892
| -37% | -$2.11M |
|
|
EVRI
1705
DELISTED
Everi Holdings
EVRI
| $3.62M | ﹤0.01% |
431,075
+34,804
| +9% | +$284K |
|
1706
Bankunited
BKU
$3.48B
| $3.62M | ﹤0.01% |
123,596
-95,259
| -44% | -$2.65M |
|
1707
CALL
BioNTech
BNTX
$23.1B
| $3.62M | ﹤0.01% |
+45,000
| New | +$4.11M |
|
1708
NMI Holdings
NMIH
$3.36B
| $3.61M | ﹤0.01% |
106,190
-28,526
| -21% | -$918K |
|
1709
Icon
ICLR
$12.1B
| $3.6M | ﹤0.01% |
11,486
-86,676
| -88% | -$27.2M |
|
1710
CALL
eBay
EBAY
$48.4B
| $3.6M | ﹤0.01% |
67,000
-50,000
| -43% | -$2.61M |
|
|
COOP
1711
DELISTED
Mr. Cooper
COOP
| $3.6M | ﹤0.01% |
44,305
-14,709
| -25% | -$1.18M |
|
1712
Upwork
UPWK
$1.18B
| $3.59M | ﹤0.01% |
334,215
-72,472
| -18% | -$822K |
|
1713
CALL
Cheesecake Factory
CAKE
$5.25B
| $3.59M | ﹤0.01% |
+91,400
| New | +$3.39M |
|
1714
Monro
MNRO
$409M
| $3.58M | ﹤0.01% |
150,090
+117,370
| +359% | +$3.13M |
|
1715
CALL
Sea Limited
SE
$68.5B
| $3.57M | ﹤0.01% |
+50,000
| New | +$3.3M |
|
1716
Polaris
PII
$4.19B
| $3.54M | ﹤0.01% |
45,261
-48,442
| -52% | -$4.1M |
|
1717
CRISPR Therapeutics
CRSP
$5.2B
| $3.54M | ﹤0.01% |
65,620
-190,711
| -74% | -$11M |
|
1718
Viavi Solutions
VIAV
$10.1B
| $3.54M | ﹤0.01% |
515,368
-14,631
| -3% | -$114K |
|
1719
Upstart Holdings
UPST
$2.93B
| $3.53M | ﹤0.01% |
149,809
-420,240
| -74% | -$10.1M |
|
1720
CALL
Dow Inc
DOW
$21.9B
| $3.52M | ﹤0.01% |
66,300
+38,200
| +136% | +$2.18M |
|
1721
Jazz Pharmaceuticals
JAZZ
$16.3B
| $3.51M | ﹤0.01% |
32,921
-65,135
| -66% | -$7.16M |
|
1722
Axalta
AXTA
$8.06B
| $3.51M | ﹤0.01% |
102,735
-155,413
| -60% | -$5.31M |
|
1723
Krystal Biotech
KRYS
$9.7B
| $3.51M | ﹤0.01% |
19,088
-2,526
| -12% | -$424K |
|
1724
Xerox
XRX
$421M
| $3.5M | ﹤0.01% |
301,606
+58,678
| +24% | +$852K |
|
1725
ScottsMiracle-Gro
SMG
$3.88B
| $3.5M | ﹤0.01% |
53,732
-30,536
| -36% | -$2.09M |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.